Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
JCO Precision Oncology
|
April 3, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer
Daniel Walden, Felipe Batalini, Cody Eslinger, et al.
Breast Cancer Research and Treatment
|
April 16, 2026
Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis
Lorrany Larisse Costa Rodrigues, Lara de Holanda Jucá Silveira, Luiz Felipe C de Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2025
Erratum: Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
Bhavika K Patel, Molly B Carnahan, Donald Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2024
Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
Bhavika K Patel, Molly B Carnahan, Donald Northfelt, et al.
Cancer Communications (London, England)
|
October 10, 2024
Genomic imprinting biomarkers for cervical cancer risk stratification
Xue Xiao, Wei Wang, Peng Bai, et al.
Clinical Breast Cancer
|
November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Cell Reports
|
October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Lin Wang, Dan Wang, Olmo Sonzogni, et al.
Research Square
|
January 30, 2023
Reciprocal inhibition of PIN1 and APC/C<sub>CDH1</sub> controls timely G1/S transition and creates therapeutic vulnerability
Shizhong Ke, Fabin Dang, Lin Wang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
JCO Precision Oncology
|
April 3, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer
Daniel Walden, Felipe Batalini, Cody Eslinger, et al.
Breast Cancer Research and Treatment
|
April 16, 2026
Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis
Lorrany Larisse Costa Rodrigues, Lara de Holanda Jucá Silveira, Luiz Felipe C de Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2025
Erratum: Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
Bhavika K Patel, Molly B Carnahan, Donald Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2024
Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
Bhavika K Patel, Molly B Carnahan, Donald Northfelt, et al.
Cancer Communications (London, England)
|
October 10, 2024
Genomic imprinting biomarkers for cervical cancer risk stratification
Xue Xiao, Wei Wang, Peng Bai, et al.
Clinical Breast Cancer
|
November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Cell Reports
|
October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Lin Wang, Dan Wang, Olmo Sonzogni, et al.
Research Square
|
January 30, 2023
Reciprocal inhibition of PIN1 and APC/C<sub>CDH1</sub> controls timely G1/S transition and creates therapeutic vulnerability
Shizhong Ke, Fabin Dang, Lin Wang, et al.
Page
of 6